Back

From Resistance to Recognition: Enhancing Care for Neuroendocrine and High-Risk Prostate Cancer Phenotypes

Neuroendocrine prostate cancer (NEPC) and other aggressive histologic variants of prostate cancer (PC) represent rare but clinically devastating disease phenotypes. These tumors progress and often evade detection through conventional measures such as PSA monitoring and standard biopsies creating challenges for timely recognition and optimal treatment selection. As a result, patients may miss opportunities for early therapeutic intervention and access to novel therapies. In this CE Concepts infographic, the multidisciplinary care team will be equipped with practical strategies to improve recognition, diagnostic accuracy, and coordinated care for NEPC and other high-risk prostate cancer phenotypes. Faculty experts will showcase how a collaborative approach that integrates advanced imaging, histopathology, and molecular profiling together with the latest advances in biomarkers, therapies, and clinical trial opportunities translates cutting-edge science into actionable clinical pearls. By leveraging innovative, interactive education, this program will empower oncologists, urologists, radiologists, pathologists, advanced practitioners, and the broader multidisciplinary team with strategies that can be applied immediately to ensure timely evidence-based decisions and improve patient outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1 creditAAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

ABIM — Medical KnowledgeUp to 1 point

FDA REMS

No

Qualifies for MIPS

Yes

Pricing

Free

Reported to ACCME by the provider

  • Microlearning
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Commercial Support
  • Released
    Dec 19, 2025
  • Last day to claim credit
    Jan 28, 2027 4 months left